Skip to main content
. 2021 Apr 30;30(2):149–154. doi: 10.7570/jomes20121

Table 1.

The demographic characteristics of diabetic patients with COVID-19

Demographic variable Total (n = 317) Non-obese patient (BMI < 30 kg/m2, n = 241) Obese patient (BMI ≥ 30 kg/m2, n = 76) P
Age (yr) 65.09 ± 13.29 65.99 ± 12.97 62.89 ± 13.93 0.14*
Sex < 0.01
Male 163 (51.4) 133 (55.1) 30 (39.5)
Female 155 (48.8) 108 (44.8) 46 (60.5)
Comorbidity
CVD 111 (35.0) 86 (35.6) 25 (32.8) 0.49
Respiratory disease 48 (15.1) 37 (15.3) 11 (14.4) 0.55
HTN 200 (63.1) 151 (62.6) 49 (64.4) 0.39
Kidney disease 58 (16.0) 46 (19.1) 12 (15.8) 0.44
Carcinoma 19 (5.9) 14 (5.8) 5 (6.5) 0.50
Liver disease 8 (2.5) 4 (1.6) 4 (5.2) 0.15
Autoimmune disease 5 (1.5) 2 (0.8) 3 (3.9) 0.21
Smoker 17 (5.4) 14 (5.8) 3 (3.9) 0.43
Antidiabetic agent use 0.34
Insulin 107 (33.7) 76 (31.5) 31 (40.7)
Oral agent 196 (61.8) 155 (64.3) 41 (53.9)
Combination insulin/oral agent 14 (4.4) 10 (4.1) 4 (5.2)
SBP (mmHg) 125.55 ± 17.26 125.30 ± 17.01 125.67 ± 17.68 0.88*
FBG (mg/dL) 170.40 ± 26.37 169.30 ± 23.47 186.70 ± 24.21 0.07*
ALT (IU/L) 25.90 ± 18.27 24.41 ± 20.55 26.55 ± 13.82 0.57*
AST (IU/L) 35.93 ± 12.70 30.32 ± 11.67 37.96 ± 14.92 0.04*
Creatinine (mg/dL) 1.89 ± 1.81 1.97 ± 1.85 1.77 ± 1.84 0.49*
hs-CRP 5.30 ± 1.28 6.30 ± 1.41 6.66 ± 2.73 0.63*
GCS < 15 105 (33.1) 82 (34.4) 23 (30.2) 0.45
RR ≥ 22 60 (18.9) 46 (19.5) 14 (18.4) 0.76
SBP < 100 mmHg 33 (10.7) 21 (8.2) 12 (15.7) 0.06
BUN > 19 197 (62.1) 147 (60.9) 50 (65.7) 0.47

Values are presented as mean± standard deviation or number (%).

*Independent t-test; Chi-square test.

COVID-19, coronavirus disease 2019; BMI, body mass index; CVD, cardiovascular disease; HTN, hypertension; SBP, systolic blood pressure; FBG, fasting blood glucose; ALT, alanine amino transferase; AST, aspartate amino transferase; hs-CRP, high sensitive-C reactive protein; GCS, Glasgow Coma Scale; RR, respiratory rate; BUN, blood urea nitrogen.